Dermatological and Cardiac Manifestations of Wegener's Disease
Main Article Content
Abstract
Wegener's disease, also known as Granulomatosis with Polyangiitis (GPA), is a rare autoimmune disorder that affects small- to medium-sized blood vessels, causing inflammation and damage to various organs. The disease commonly involves the respiratory tract, kidneys, and the skin. In terms of dermatological symptoms, patients may develop purpura, which are small red or purple spots on the skin caused by bleeding under the skin, or nodules or ulcers that may be painful or non-painful. These lesions can occur anywhere on the body but are often found on the lower legs. Vascular involvement can lead to necrotizing vasculitis, which can be life-threatening if not treated promptly. Early diagnosis and treatment with immunosuppressive therapy can help manage the symptoms and prevent organ damage.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85
II. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-429.
III. Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med 1983; 208: 435-460.
IV. Cardiac complications of Wegener's granulomatosis: a case report of complete heart block and review of the literature. Semin Arthritis Rheum 1980; 10: 148-154.
V. Wegener's granulomatosis and the heart. Br Heart J 1994; 71: 82-86.
VI. Reversible valvulitis in Wegener's granulomatosis. Chest 1987; 92: 182-183
VII. Myocardial infarction in Wegener's Granulomatosis. Aust NZ J Med 1976; 6: 336-340.
VIII. The Churg-Strauss syndrome. A case report with angiographically documented coronary involvement and a review of the literature. Chest 1995; 107: 578-580.
IX. Wegener's granulomatosis-report of four cases including two in patients who died of myocardial infarction. Nippon Kyobu Shikkan Gakkai Zasshi 1994; 3: 988-993.
X. Vera-Lastra OL, Halabe-Cherem J, Jara LJ. Systemic vasculitis. General concepts. In: Vera-Lastra OL, Halabe-Cherem J, eds. Vasculitis. Mexico: Alfil; 2006. pp. 1-4.
XI. Klinger H. Grenzformen der periarteritis nodosa. Frankf Ztschr Pathol 1931;42:455-480.
XII. Wegener F. Uber eine eigenartige rhinogene granulomatose mit besonderer beteilingung des arteriensystems und der neiren. Beitr Pathol Anat Allg Pathol 1939;102:36-68.
XIII. Goodman GC, Churg J. Wegener's granulomatosis: pathology and review of the literature. Arch Pathol 1954;58:533-553.
XIV. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:15121523.
XV. Osaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int 2007;56:87-96.
XVI. Vera-Lastra OL. Diagnostic approach to vasculitis. In: Vera-Lastra OL, Halabe Cherem J, eds. Vasculitis. Mexico: Alfil; 2006. pp. 77-99. 128
XVII. Pesci A, Manganelli P. Involvement of the respiratory system an ANCAassociated systemic vasculitides: clinical and pathologic hallmarks and treatment. Drugs 2007;8:25-42.
XVIII. Pagnoux C, Teixeira L. Wegener's granulomatosis. Presse Med 2007;36(5Pt 2):860-874.
XIX. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nölle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatois: long term outcome of 155 patients. Arthritis Rheum 2000;43:10211032.